Immatics (IMTX) Cash & Equivalents (2019 - 2025)

Immatics' (IMTX) quarterly Cash & Equivalents came in at $275.6 million in Q4 2025, up 18.04% year-on-year from $233.5 million in Q4 2024, and little changed quarter-over-quarter from $276.8 million in Q3 2025.

Immatics (IMTX) Cash & Equivalents (2019 - 2025) Analysis & Trends

Immatics has disclosed Cash & Equivalents across 7 years of filings, most recently posting $275.6 million for Q4 2025.

  • Cash & Equivalents for Q4 2025 came in at $275.6 million, up 18.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $275.6 million (up 18.04% YoY), and the FY2025 annual result was $267.5 million, up 14.57% from the prior year.
  • Cash & Equivalents came in at $275.6 million for Q4 2025 at Immatics, roughly flat from $276.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $290.5 million in Q2 2025 to a low of $134.1 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $235.2 million (2024), against an average of $211.8 million.
  • Across the five-year window, Cash & Equivalents soared 119.54% in 2021 and sank 45.21% in 2022, its largest moves.
  • Immatics' Cash & Equivalents stood at $152.1 million in 2021, then fell by 0.4% to $151.5 million in 2022, then soared by 55.13% to $235.1 million in 2023, then declined by 0.68% to $233.5 million in 2024, then gained by 18.04% to $275.6 million in 2025.
  • The last three Cash & Equivalents figures came in at $275.6 million (Q4 2025), $276.8 million (Q3 2025), and $290.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Immatics 14.67 Bn 14.67 Bn - 275.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 275.58 Mn
Sep 30, 2025 276.77 Mn
Jun 30, 2025 290.50 Mn
Mar 31, 2025 255.44 Mn
Dec 31, 2024 233.46 Mn
Sep 30, 2024 239.93 Mn
Jun 30, 2024 235.27 Mn
Mar 31, 2024 237.34 Mn
Dec 31, 2023 235.06 Mn
Sep 30, 2023 161.68 Mn
Jun 30, 2023 161.73 Mn
Mar 31, 2023 159.41 Mn
Dec 31, 2022 151.53 Mn
Sep 30, 2022 134.09 Mn
Jun 30, 2022 141.91 Mn
Mar 31, 2022 149.26 Mn
Dec 31, 2021 152.14 Mn
Sep 30, 2021 244.74 Mn
Jun 30, 2021 249.92 Mn
Mar 31, 2021 250.33 Mn